Cardiovascular Risk Assessment and Prevention in Cardio-Oncology: Beyond Traditional Risk Factors

Omar M Makram; Priyanshu Nain; Alexi Vasbinder; Neal L Weintraub; Avirup Guha

doi:10.1016/j.ccl.2024.08.003

Cardiovascular Risk Assessment and Prevention in Cardio-Oncology: Beyond Traditional Risk Factors

Cardiol Clin. 2025 Feb;43(1):1-11. doi: 10.1016/j.ccl.2024.08.003. Epub 2024 Sep 25.

Authors

Omar M Makram¹, Priyanshu Nain², Alexi Vasbinder³, Neal L Weintraub², Avirup Guha⁴

Affiliations

¹ Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; Department of Medicine, Cardio-Oncology Program, Cardiology Division, Medical College of Georgia at Augusta University, Augusta, GA, USA.
² Department of Medicine, Cardio-Oncology Program, Cardiology Division, Medical College of Georgia at Augusta University, Augusta, GA, USA; Division of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
³ Department of Biobehavioral Nursing and Health Informatics, School of Nursing, University of Washington, Seattle, WA, USA.
⁴ Department of Medicine, Cardio-Oncology Program, Cardiology Division, Medical College of Georgia at Augusta University, Augusta, GA, USA; Division of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA. Electronic address: [email protected].

PMID: 39551552
DOI: 10.1016/j.ccl.2024.08.003

Abstract

This review goes beyond traditional approaches in cardio-oncology, highlighting often-neglected factors impacting patient care. Social determinants, environment, health care access, and gut microbiome significantly influence patient outcomes. Powerful tools like multi-omics and wearable technologies offer deeper insights into real-world experiences. The future lies in integrating these advancements with established practices to achieve precision cardio-oncology care. By crafting tailored therapies and continuously updating comprehensive management plans based on real-time data, we can unlock the full potential of personalized care for all patients.

Keywords: Cardio-oncology; Gut microbiome; Machine learning; Multi-omics; Precision medicine; Real-time data; Social determinants; Wearable technology.

Publication types

Review

MeSH terms

Cardio-Oncology
Cardiology
Cardiovascular Diseases* / prevention & control
Heart Disease Risk Factors
Humans
Medical Oncology* / methods
Neoplasms* / complications
Risk Assessment / methods
Risk Factors